Ignite Creation Date:
2024-05-05 @ 6:38 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00511173
Status:
COMPLETED
Last Update Posted:
2012-12-11
First Post:
2007-08-01
Brief Title:
Comparison of Warfarin Dosing Using Decision Model Versus Pharmacogenetic Algorithm
Sponsor:
Creighton University
Organization:
Creighton University
Study Overview
Official Title:
Warfarin Dosing Pharmacogenetic Algorithm Compared to Pharmacists Dosing
Status:
COMPLETED
Status Verified Date:
2012-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a prospective comparison of clinician dosing and a pharmacogenetic algorithm in diagnosed patients requiring warfarin therapy
Detailed Description:
Diagnosed patients with atrial fibrillation pulmonary embolism or deep venous thrombosis requiring warfarin therapy will be consented and a tube of blood for DNA analysis will be drawn The clinician dosing group will not be eligible to obtain the pharmacogenetic results and the algorithm group will have their warfarin pharmacogenetic SNPs performed and integrated into the algorithm and the warfarin dose will be calculated Outcomes of patients receiving both methods will be gathered and statistically analyzed
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None